MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
基本信息
- 批准号:2909331
- 负责人:
- 金额:$ 33.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-07-01 至 2003-05-31
- 项目状态:已结题
- 来源:
- 关键词:analytical ultracentrifugation apolipoproteins chemical binding conformation crosslink fluorescence resonance energy transfer high density lipoproteins infrared spectrometry interferometry mutant phosphatidylcholine sterol acyltransferase physical model protein structure function structural biology thermodynamics
项目摘要
DESCRIPTION (Adapted from abstract): Apolipoprotein A-I (apo A-I) is the major protein found in high density lipoprotein (HDL) an has been implicated in all of the known physiological functions of HDL, including the protective effect of HDL against coronary artery disease and atherosclerosis. One important question in this field is the role that apo A-I structure plays in the conversion of the protein from its lipid-free to lipid-bound conformation(s). This question has been the subject of substantial testing by a variety of biochemical, biophysical, and genetic techniques. The diverse approaches used to address this question have led to the development of several competing models for the structure of apo A-I in its lipid-free and lipid-bound conformations. Rigorous testing of the predictions of these competing models is the focus of this revised application. The research team determined the first atomic resolution for an apo A-I mutant [Borhani, et al 1997]. The information contained in this structure (currently being refined at 3 angstroms) provides a framework for testing the predictions of the various competing models for apo A-I structure. The two specific aims are: 1. What is the physiologically relevant structure of lipid free apo A-I? (a) Is it a globule, a rod or both? (b) Does it have a discrete tertiary structure or is it a "molten globule" with no distinct tertiary structure? 2. What is the conformation of lipid-bound apo A-I? (a) Is it a discrete structure when bound to discoidal lipid complexes (described as either a "picket fence" or a "belt" with defined interhelical pairing), or are there less defined conformations that have no distinct tertiary structure or interhelical pairing? A variety of methods will be employed to test predictions of the various models, such as cysteine crosslinking, pyrene excimer formation, fluorescence resonance energy transfer (FRET), analytical ultracentrifugation, thermodynamic stability, polarized attenuated internal reflection Fourier transform infrared spectroscopy (PATIR-FITR), and lipid binding kinetics. In the long term, these studies will help determine which of the competing models may be physiologically relevant and help us understand lipid and cholesterol metabolism.
描述(改编自摘要):载脂蛋白A-I(APO A-I)是在高密度脂蛋白(HDL)A中发现的主要蛋白,A A均与HDL的所有已知生理功能有关,包括HDL对冠状动脉疾病和动脉粥样硬化的保护作用。在该领域,一个重要的问题是Apo A-I结构在蛋白质从无脂质结合构象的转化中发挥的作用。这个问题是通过多种生化,生物物理和遗传技术进行实质性测试的主题。用于解决这个问题的多种方法导致了在无脂质和脂质结合构象中APO A-I结构的几种竞争模型的发展。对这些竞争模型的预测进行严格的测试是该修订应用程序的重点。研究小组确定了Apo A-I突变体的第一个原子分辨率[Borhani等,1997]。该结构中包含的信息(目前正在3埃埃斯特罗姆)提供了一个框架,用于测试APO A-I结构的各种竞争模型的预测。两个具体的目的是:1。脂质无脂质A-I的生理相关结构是什么? (a)是球,杆还是两者? (b)它是否具有离散的三级结构,还是没有独特的三级结构的“熔融球”? 2。脂质结合的apo a-i的构象是什么? (a)当碰到盘状脂质复合物(被描述为“纠察栅栏”或具有定义的螺旋间配对的“皮带”)时,它是一个离散的结构吗?还是没有明确的构型,没有明显的第三结构或螺旋间配对?将采用多种方法来测试各种模型的预测,例如半胱氨酸交联,吡啶素进剂形成,荧光谐振能量传递(FRET),分析性超速离心,热力学稳定性,极化衰减减弱的内部反射傅立傅立傅立叶傅立叶傅立叶傅立叶傅立叶转化基础光谱(patir-fransic fransforcoppy(patir-fitrscoppocy(patir-fitr))和lipics和lipidics和lipidic binipics and lipidics和kineting bineting iniging inigindInding iniging intingInding anding nigiting intinging nigning anding intinging。从长远来看,这些研究将有助于确定哪些竞争模型在生理上可能相关,并帮助我们了解脂质和胆固醇代谢。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christie G. Brouillette其他文献
Functional Stabilization of Purified Human CFTR by NBD1 Mutations and by Phosphatidylserine
- DOI:
10.1016/j.bpj.2017.11.1365 - 发表时间:
2018-02-02 - 期刊:
- 影响因子:
- 作者:
Ina Urbatsch;Zhengrong Yang;Ellen Hildebrandt;Fan Jiang;Qingxian Zhou;Jiangli An;Bala M. Xavier;Netaly Khazanov;Hanoch Senderowitz;John C. Kappes;Christie G. Brouillette - 通讯作者:
Christie G. Brouillette
Christie G. Brouillette的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christie G. Brouillette', 18)}}的其他基金
MicroCal Auto-iTC200; automated high sensitivity isothermal titration calorimetry
MicroCal Auto-iTC200;
- 批准号:
7793137 - 财政年份:2009
- 资助金额:
$ 33.01万 - 项目类别:
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
炭疽、鼠疫和兔热病药物的发现和临床前开发
- 批准号:
7285619 - 财政年份:2006
- 资助金额:
$ 33.01万 - 项目类别:
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
炭疽、鼠疫和兔热病药物的发现和临床前开发
- 批准号:
7134554 - 财政年份:2006
- 资助金额:
$ 33.01万 - 项目类别:
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
炭疽、鼠疫和兔热病药物的发现和临床前开发
- 批准号:
7485731 - 财政年份:2006
- 资助金额:
$ 33.01万 - 项目类别:
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
炭疽、鼠疫和兔热病药物的发现和临床前开发
- 批准号:
7676868 - 财政年份:2006
- 资助金额:
$ 33.01万 - 项目类别:
Discovery and Preclinical Development of Drugs for Anthrax, Plague and Tularemia
炭疽、鼠疫和兔热病药物的发现和临床前开发
- 批准号:
7906663 - 财政年份:2006
- 资助金额:
$ 33.01万 - 项目类别:
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6537486 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6184875 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6390114 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
相似国自然基金
中性粒细胞明胶酶相关载脂蛋白诱导血液高凝的分子机理研究
- 批准号:32371162
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
载脂蛋白H(APOH)促进主动脉夹层发生发展作用机制研究
- 批准号:82370470
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
载脂蛋白A-IV在Stevens-Johnson综合征/中毒性表皮坏死松解症炎症反应中的作用及机制研究
- 批准号:82373469
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
载脂蛋白C3通过促进铁死亡加重血管钙化的作用及机制研究
- 批准号:82370454
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
利用新型基因敲除家兔模型揭示载脂蛋白A-V在高甘油三酯血症及动脉粥样硬化中的作用机制
- 批准号:82200504
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6537486 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6184875 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
MOLECULAR BASIS FOR APOLIPOPROTEIN AI FUNCTION
载脂蛋白 AI 功能的分子基础
- 批准号:
6390114 - 财政年份:1999
- 资助金额:
$ 33.01万 - 项目类别:
MACROMOLECULES OF CIRCULATORY AND GENETIC IMPORTANCE
具有循环和遗传重要性的大分子
- 批准号:
3268561 - 财政年份:1976
- 资助金额:
$ 33.01万 - 项目类别:
MACROMOLECULES OF CIRCULATORY AND GENETIC IMPORTANCE
具有循环和遗传重要性的大分子
- 批准号:
3268555 - 财政年份:1976
- 资助金额:
$ 33.01万 - 项目类别: